Thanks, Daniel Levine, for this opportunity to talk about what makes Aulos Bioscience unique in our approach and how AU-007 is a promising therapeutic agent for cancer in the IL-2 space. What a great discussion, as always. #science #innovation
We’re fortunate to have AU-007, our computationally designed monoclonal antibody, featured on The Bio Report podcast with Daniel Levine. Listen to this in-depth discussion with our CEO, Aron Knickerbocker, discussing how we’re working to transform the treatment paradigm in the IL-2 class. #AU007 #innovation
CEO and Founder of Genoplex.ai | Comms Committee @ ASGCT | Host of Rx for Biotech Podcast & TEDx Speaker
9moThanks for sharing this podcast interview which is an excellent IL2 biology 🧬 primer Aron